639 related articles for article (PubMed ID: 22366579)
1. Tumor necrosis factor-associated susceptibility to type 1 diabetes is caused by linkage disequilibrium with HLA-DR3 haplotypes.
Kumar N; Kaur G; Tandon N; Mehra N
Hum Immunol; 2012 May; 73(5):566-73. PubMed ID: 22366579
[TBL] [Abstract][Full Text] [Related]
2. Type 1 diabetes in the Spanish population: additional factors to class II HLA-DR3 and -DR4.
Urcelay E; Santiago JL; de la Calle H; Martínez A; Méndez J; Ibarra JM; Maluenda C; Fernández-Arquero M; de la Concha EG
BMC Genomics; 2005 Apr; 6():56. PubMed ID: 15842729
[TBL] [Abstract][Full Text] [Related]
3. Association and interaction of the TNF-alpha gene with other pro- and anti-inflammatory cytokine genes and HLA genes in patients with type 1 diabetes from North India.
Kumar R; Goswami R; Agarwal S; Israni N; Singh SK; Rani R
Tissue Antigens; 2007 Jun; 69(6):557-67. PubMed ID: 17498265
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms of TNF microsatellite marker a and HLA-DR-DQ in diabetes mellitus-a study in 609 Swedish subjects.
Törn C; Hillman M; Sanjeevi CB; Landin-Olsson M
Hum Immunol; 2006 Jul; 67(7):527-34. PubMed ID: 16829307
[TBL] [Abstract][Full Text] [Related]
5. Linkage disequilibrium with predisposing DR3 haplotypes accounts for apparent effects of tumor necrosis factor and lymphotoxin-alpha polymorphisms on type 1 diabetes susceptibility.
Noble JA; Valdes AM; Lane JA; Green AE; Erlich HA
Hum Immunol; 2006 Dec; 67(12):999-1004. PubMed ID: 17174749
[TBL] [Abstract][Full Text] [Related]
6. Identification of specific tumor necrosis factor-α-susceptible and -protective haplotypes associated with the risk of type 1 diabetes.
Stayoussef M; Benmansour J; Al-Jenaidi FA; Rajab MH; Said HB; Ourtani M; Rayana CB; Mahjoub T; Almawi WY
Eur Cytokine Netw; 2010 Dec; 21(4):285-91. PubMed ID: 21097392
[TBL] [Abstract][Full Text] [Related]
7. Human leukocyte antigen-B8-DR3 is a more important risk factor for severe Puumala hantavirus infection than the tumor necrosis factor-alpha(-308) G/A polymorphism.
Mäkelä S; Mustonen J; Ala-Houhala I; Hurme M; Partanen J; Vapalahti O; Vaheri A; Pasternack A
J Infect Dis; 2002 Sep; 186(6):843-6. PubMed ID: 12198621
[TBL] [Abstract][Full Text] [Related]
8. TNFa microsatellite polymorphism modulates the risk of type 1 diabetes in the Belgian population, independent of HLA-DQ.
Aminkeng F; Van Autreve JE; Koeleman BP; Quartier E; Van Schravendijk C; Gorus FK; Van der Auwera BJ;
Hum Immunol; 2007 Aug; 68(8):690-7. PubMed ID: 17678725
[TBL] [Abstract][Full Text] [Related]
9. Allotyping human complement factor B in Asian Indian type 1 diabetic patients.
Kumar N; Kaur G; Tandon N; Mehra NK
Tissue Antigens; 2008 Dec; 72(6):517-24. PubMed ID: 19000152
[TBL] [Abstract][Full Text] [Related]
10. Linkage disequilibrium with HLA-DRB1-DQB1 haplotypes explains the association of TNF-308G>A variant with type 1 diabetes in a Brazilian cohort.
Patente TA; Monteiro MB; Vieira SM; Rossi da Silva ME; Nery M; Queiroz M; Azevedo MJ; Canani LH; Parisi MC; Pavin EJ; Mainardi D; Javor J; Velho G; Coimbra CN; Corrêa-Giannella ML
Gene; 2015 Aug; 568(1):50-4. PubMed ID: 25965561
[TBL] [Abstract][Full Text] [Related]
11. TNF-308A and HLA-DR3 alleles contribute independently to susceptibility to systemic lupus erythematosus.
Rood MJ; van Krugten MV; Zanelli E; van der Linden MW; Keijsers V; Schreuder GM; Verduyn W; Westendorp RG; de Vries RR; Breedveld FC; Verweij CL; Huizinga TW
Arthritis Rheum; 2000 Jan; 43(1):129-34. PubMed ID: 10643708
[TBL] [Abstract][Full Text] [Related]
12. TNF2, a polymorphism of the tumour necrosis-alpha gene promoter, is a component of the celiac disease major histocompatibility complex haplotype.
McManus R; Wilson AG; Mansfield J; Weir DG; Duff GW; Kelleher D
Eur J Immunol; 1996 Sep; 26(9):2113-8. PubMed ID: 8814255
[TBL] [Abstract][Full Text] [Related]
13. Contribution of MHC class I chain-related A (MICA) gene polymorphism to genetic susceptibility for systemic lupus erythematosus.
Gambelunghe G; Gerli R; Bocci EB; Del Sindaco P; Ghaderi M; Sanjeevi CB; Bistoni O; Bini V; Falorni A
Rheumatology (Oxford); 2005 Mar; 44(3):287-92. PubMed ID: 15522921
[TBL] [Abstract][Full Text] [Related]
14. Independent association of tumor necrosis factor polymorphism with type 1 diabetes susceptibility.
Shin HD; Yang SW; Kim DH; Park Y
Ann N Y Acad Sci; 2008 Dec; 1150():76-85. PubMed ID: 19120272
[TBL] [Abstract][Full Text] [Related]
15. Biomarkers of susceptibility to type 1 diabetes with special reference to the Indian population.
Mehra NK; Kumar N; Kaur G; Kanga U; Tandon N
Indian J Med Res; 2007 Mar; 125(3):321-44. PubMed ID: 17496359
[TBL] [Abstract][Full Text] [Related]
16. Genetic evaluation of the TNF-α -238G>A and -308G>A promoter polymorphisms in Croatian patients with type I diabetes.
Korolija M; Hadžija M; Medvidović EP; Pavkovic P; Kapitanović S; Renar IP; Hadžija MP
Hum Immunol; 2010 Dec; 71(12):1228-32. PubMed ID: 20849900
[TBL] [Abstract][Full Text] [Related]
17. TNFa-e microsatellite, HLA-DRB1 and -DQB1 alleles and haplotypes in Brazilian patients presenting recently diagnosed type 1 diabetes mellitus.
Rassi DM; Wastowski IJ; Simões RT; Rodrigues S; Deghaide NN; Mendes-Junior CT; Simões AL; Soares CP; Passos GA; Donadi EA
Ann N Y Acad Sci; 2006 Oct; 1079():300-4. PubMed ID: 17130569
[TBL] [Abstract][Full Text] [Related]
18. Primary sclerosing cholangitis is associated with extended HLA-DR3 and HLA-DR6 haplotypes.
Wiencke K; Karlsen TH; Boberg KM; Thorsby E; Schrumpf E; Lie BA; Spurkland A
Tissue Antigens; 2007 Feb; 69(2):161-9. PubMed ID: 17257319
[TBL] [Abstract][Full Text] [Related]
19. STAT4 polymorphism is associated with early-onset type 1 diabetes, but not with late-onset type 1 diabetes.
Lee HS; Park H; Yang S; Kim D; Park Y
Ann N Y Acad Sci; 2008 Dec; 1150():93-8. PubMed ID: 19120275
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms in the genes encoding TGF-beta1, TNF-alpha, and IL-6 show association with type 1 diabetes mellitus in the Slovak population.
Javor J; Ferencik S; Bucova M; Stuchlikova M; Martinka E; Barak L; Strbova L; Grosse-Wilde H; Buc M
Arch Immunol Ther Exp (Warsz); 2010 Oct; 58(5):385-93. PubMed ID: 20686866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
